Skip to main content
  • Home
  • Scheme Overview

Tata India Pharma & Healthcare Fund-Regular Plan-Growth

Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 28-12-2015
Asset Class: Equity
Benchmark: NIFTY Pharma TRI
Expense Ratio: 2.21% As on (30-04-2026)
Status: Open Ended Schemes
Minimum Investment: 5000.0
Minimum Topup: 1000.0
Total Assets: 1,228.79 Cr As on (31-03-2026)
Turn over: 94.2
NAV (₹): 31.5683
₹ 0.2 ( 0.6231%)
as on 11-05-2026
CAGR Since Inception - 11.68%
NIFTY Pharma TRI - 14.37%

Fund Managers

Rajat Srivastava


Investment Objective

The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

PERFORMANCE of Tata India Pharma & Healthcare Fund-Regular Plan-Growth

Scheme Performance (%) Data as on - 11-05-2026

1-Year Ret (%) 3-Yrs Ret (%) 5-Yrs Ret (%) 10-Yrs Ret (%) Since Launch Ret (%)
Tata India Pharma & Healthcare Fund-Regular Plan-Growth 10.3 23.79 13.74 12.76 11.68
Nifty Pharma TRI 15.45 25.29 12.26 8.76 14.37
Equity: Sectoral-Pharma and Healthcare 14.24 24.65 13.92 13.45 14.72

RETURNS CALCULATOR for Tata India Pharma & Healthcare Fund-Regular Plan-Growth

Growth of 10000 In SIP (Fund vs Benchmark)

Amount :
Period :
Start :
End :

Growth of 10000 In LUMPSUM (Fund vs Benchmark)

Amount :
Start :

Rolling Returns

Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.

Key Performance and Risk Statistics of Tata India Pharma & Healthcare Fund-Regular Plan-Growth

Key Statistics Volatility Sharpe Ratio Alpha Beta Yield to Maturity Average Maturity
Tata India Pharma & Healthcare Fund-Regular Plan-Growth 14.23 0.95 -0.05 0.97 - -
Equity: Sectoral-Pharma and Healthcare - - - - - -

PEER COMPARISION

Scheme Name Launch
Date
1-Year
Ret (%)
2-Yrs
Ret (%)
3-Yrs
Ret (%)
5-Yrs
Ret (%)
10-Yrs
Ret (%)
Tata India Pharma & Healthcare Reg Gr 28-12-2015 10.3 12.8 23.79 13.74 12.76
HDFC Pharma and Healthcare Fund Gr 04-10-2023 22.56 24.26 0.0 0.0 0.0
WhiteOak Capital Pharma and Heathcare Fund Reg Plan Gr 06-02-2024 19.8 22.59 0.0 0.0 0.0
Mirae Asset Healthcare Reg Gr 10-07-2018 17.78 17.17 25.86 14.61 0.0
Kotak Healthcare Reg Gr 11-12-2023 17.71 15.7 0.0 0.0 0.0
UTI Healthcare Reg Gr 05-08-2005 15.1 17.42 26.65 13.97 13.28
ABSL Pharma and Healthcare Reg Gr 05-07-2019 15.01 13.18 24.56 12.85 0.0
PGIM India Healthcare Fund Reg Gr 19-11-2024 14.85 0.0 0.0 0.0 0.0
BAJAJ FINSERV HEALTHCARE FUND REG GR 27-12-2024 14.77 0.0 0.0 0.0 0.0
LIC MF Healthcare Fund Reg Gr 22-02-2019 13.9 14.56 23.57 11.06 0.0

Asset Allocation (%)

PORTFOLIO ANALYSIS of Tata India Pharma & Healthcare Fund-Regular Plan-Growth

Portfolio as on

Top 10 Sectors in portfolio (%)

Top 10 Stocks in portfolio (%)